FACEPHI BIOMETRIA SA (ALPHI.PA) Stock Analyst Earnings Estimates
EPA:ALPHI - Euronext Paris - Matif - ES0105029005 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.283M 69.30% | 25.153M 12.88% | 28.875M 14.80% | 45.478M 57.50% | 54.509M 19.86% | 50.886M -6.65% | 51.171M 0.56% | |
| EBITDA YoY % growth | 3.722M 445.19% | -606.7K -116.30% | -1.084M -78.61% | 6.12M 664.78% | 10.2M 66.67% | 10.567M 3.60% | 11.34M 7.32% | |
| EBIT YoY % growth | 1.748M 390.48% | -5.388M -408.14% | -6.672M -23.84% | -1.02M 84.71% | 4.08M 500.00% | 4.822M 18.19% | 5.811M 20.51% | |
| Operating Margin | 7.85% | -21.42% | -23.11% | -2.24% | 7.49% | 9.48% | 11.36% | |
| EPS YoY % growth | N/A | N/A -385.71% | N/A 45.00% | -0.06 45.45% | 0.18 391.17% | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 17.181M 11.54% | % | ||
| Q2 2024 Q2Q % growth | 11.694M 19.95% | % | ||
| Q4 2023 Q2Q % growth | 15.404M 6.79% | % | ||
| Q2 2023 Q2Q % growth | 9.749M 24.05% | % | ||
| Q4 2022 Q2Q % growth | 14.424M 60.05% | % | ||
| Q2 2022 Q2Q % growth | 7.859M 89.38% | % | ||
| Q4 2021 Q2Q % growth | 9.012M 92.55% | % | ||
| Q2 2021 Q2Q % growth | 4.15M 60.48% | % | ||
| Q4 2020 Q2Q % growth | 4.68M -34.37% | % | ||
| Q2 2020 Q2Q % growth | 2.586M 143.07% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 23.85% | 23.85% |